TheraNovis

History

Key milestones in TheraNovis's journey

2021
Founded
6+
Gov. Grants
₩15B+
Total Raised
10+
Partnerships

2025

2 events

Launch of semi-automated staining system

Product

Secured KRW 220M in funding from a private investment fundKRW 0M

Investment

2024

6 events

MOU signed with AtheonBio

Partnership

MOU signed with Intec Scientific

Partnership

Selected for MOTIE Materials & Components Technology Development Program (KRW 10B / 5 years)KRW 0M

Gov. Program

Initiated establishment of Boston, USA liaison office

Global

Secured KRW 1B in strategic (SI) investment from IntekPlusKRW 0M

Investment

Launch of Skin GeneCurator skin condition assessment service

Product

2023

6 events

Secured KRW 300M in TIPS fundingKRW 0M

Investment

Secured KRW 336M in strategic (SI) investmentKRW 0M

Investment

Selected for MSS Deep-Tech TIPS Program (KRW 1.5B / 3 years)KRW 0M

Gov. Program

Selected for Seoul-type TIPS Program (KRW 400M / 2 years)KRW 0M

Gov. Program

Selected for Medical Device Industry Transition Infrastructure Program

Medical

Launch of Phenoview (now AstraTSA)

Product

2022

4 events

Executing the Regional Specialized Industry Development Program (MSS)

Gov. Program

Selected for PNU Yangsan Bio Core Facility Program (KRW 600M / 3 years)KRW 0M

Grant

Selected for the KIBO Tech-Bridge Program

Grant

Selected for the Asan Medical Center Incentive Program

Medical

2021

3 events

TheraNovis Co., Ltd. Established

Founding

MOU Signed with BioActs and Six Additional Organizations

Partnership

Established Corporate R&D Centers (Hanam / Yangsan)

R&D

TheraNovis continues evolving into a global diagnostic platform company.